Lv21
172 积分 2025-02-20 加入
Phase I study of the oral GLP ‐1 receptor agonist DA ‐ 302168S : Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adults
7小时前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
7天前
已完结
A potent novel small molecule GLP-1R agonist identified by rational design and CADD
13天前
已完结
HDM1002 in Chinese Adults With Overweight/Obesity: A Randomized, Placebo‐Controlled, Ascending‐Dose Phase 1b Study
14天前
已完结
SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia
21天前
已关闭
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
21天前
已完结
A Validated Liquid Chromatography–Tandem Mass Spectrometry Assay for the Determination of NX‐5948 in Beagle Dog Plasma: Application to a Pharmacokinetic Study
1个月前
已完结
Structural pharmacology and mechanisms of GLP-1R signaling
1个月前
已完结
837-P: Efficacy and Safety of a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (HRS-7535) in Type 2 Diabetes Mellitus Patients Inadequately Controlled by Metformin
1个月前
已关闭
皖公网安备34019202002308
